LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 21 Jul 2026
Drug Safety Update

Domperidone

Published on 21 Jul 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), du…
Drug Safety Update on GOV.UK ↗ All events: Domperidone

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.